Rani Therapeutics Holdings Inc
Company Profile
Business description
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.
Contact
2051 Ringwood Avenue
San JoseCA95131
USAT: +1 408 457-3700
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
106
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,498.30 | 12.40 | -0.15% |
| CAC 40 | 7,873.83 | 23.73 | 0.30% |
| DAX 40 | 23,638.56 | 72.02 | 0.31% |
| Dow JONES (US) | 42,140.43 | 269.67 | -0.64% |
| FTSE 100 | 8,602.92 | 2.06 | -0.02% |
| HKSE | 23,432.40 | 324.13 | 1.40% |
| NASDAQ | 19,010.09 | 301.74 | 1.61% |
| Nikkei 225 | 37,930.10 | 253.16 | -0.66% |
| NZX 50 Index | 12,800.18 | 13.44 | 0.11% |
| S&P 500 | 5,886.55 | 42.36 | 0.72% |
| S&P/ASX 200 | 8,253.10 | 15.90 | -0.19% |
| SSE Composite Index | 3,373.33 | 1.54 | -0.05% |